Ignace B. Vergote: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

To the Editor

Dirk Timmerman, Herman Verrelst, William P. Collins, Thomas H. Bourne, Ignace Vergote

Journal:

Gynecologic Oncology

Year:

2001

Language:

english

File:

PDF, 27 KB

english, 2001

52

Pseudo-Meigs' Syndrome Caused by a Hydropic Degenerating Uterine Leiomyoma with Elevated CA 125

Frédéric Amant, Charlotte Gabriel, Dirk Timmerman, Ignace Vergote

Journal:

Gynecologic Oncology

Year:

2001

Language:

english

File:

PDF, 789 KB

english, 2001

53

To the Editor

Ignace Vergote, Isabel De Smet, Frédéric Amant

Journal:

Gynecologic Oncology

Year:

2002

Language:

english

File:

PDF, 17 KB

english, 2002

54

Exposure–response relationship of AMG 386 in combination with weekly paclitaxel in recurrent ovarian cancer and its implication for dose selection

Jian-Feng Lu, Erik Rasmussen, Beth Y. Karlan, Ignace B. Vergote, Lynn Navale, Mita Kuchimanchi, Rebeca Melara, Daniel E. Stepan, David M. Weinreich, Yu-Nien Sun

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2012

Language:

english

File:

PDF, 722 KB

english, 2012

55

PGF2α Levels in breast cancer tissue

Ignace Vergote, Guy Keersmaekers, Frans Uyttenbroeck, Gert M. Laekeman, Arnold G. Herman

Journal:

Prostaglandins, Leukotrienes and Medicine

Year:

1984

Language:

english

File:

PDF, 184 KB

english, 1984

56

Laparoscopy-assisted vaginal hysterectomy compared with abdominal hysterectomy in clinical stage I endometrial cancer: safety, recurrence, and long-term outcome

Ioannis Kalogiannidis, Sandrijne Lambrechts, Frederic Amant, Patrick Neven, Toon Van Gorp, Ignace Vergote

Journal:

American Journal of Obstetrics and Gynecology

Year:

2007

Language:

english

File:

PDF, 140 KB

english, 2007

57

Reply

Ignace Vergote, Ioannis Kalogiannidis, Frederic Amant

Journal:

American Journal of Obstetrics and Gynecology

Year:

2008

Language:

english

File:

PDF, 55 KB

english, 2008

58

Endometriosis and the development of malignant tumours of the pelvis. A review of literature

Toon Van Gorp, Frederic Amant, Patrick Neven, Ignace Vergote, Phillipe Moerman

Journal:

Best Practice & Research Clinical Obstetrics & Gynaecology

Year:

2004

Language:

english

File:

PDF, 198 KB

english, 2004

59

Reply

Frederic Amant, Ignace Vergote

Journal:

Gynecologic Oncology

Year:

2003

Language:

english

File:

PDF, 23 KB

english, 2003

60

Importance of the endometrioid carcinoma subtype and sarcomatous component in uterine carcinosarcoma

Frederic Amant, Ignace Vergote

Journal:

Gynecologic Oncology

Year:

2004

Language:

english

File:

PDF, 71 KB

english, 2004

61

Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma

Frederic Amant, Katrien Schurmans, Edwin Steenkiste, Lieve Verbist, Vera M Abeler, Gökhan Tulunay, Eric de Jonge, Leon Massuger, Philippe Moerman, Ignace Vergote

Journal:

Gynecologic Oncology

Year:

2004

Language:

english

File:

PDF, 221 KB

english, 2004

62

Letter to the Editor

Ignace B Vergote, F Amant

Journal:

Gynecologic Oncology

Year:

2004

Language:

english

File:

PDF, 41 KB

english, 2004

63

ERBB-2 gene overexpression and amplification in uterine sarcomas

Frederic Amant, Veerle Vloeberghs, Heidi Woestenborghs, Maria Debiec-Rychter, Lieve Verbist, Philippe Moerman, Ignace Vergote

Journal:

Gynecologic Oncology

Year:

2004

Language:

english

File:

PDF, 113 KB

english, 2004

64

Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer

Frederic Amant, Isabelle Cadron, Luca Fuso, Patrick Berteloot, Eric de Jonge, Gerd Jacomen, Johan Van Robaeys, Patrick Neven, Philippe Moerman, Ignace Vergote

Journal:

Gynecologic Oncology

Year:

2005

Language:

english

File:

PDF, 167 KB

english, 2005

65

CD10, estrogen and progesterone receptor expression in ovarian adenosarcoma

Tim Van Mieghem, Vera M. Abeler, Philippe Moerman, Lieve Verbist, Ignace Vergote, Frederic Amant

Journal:

Gynecologic Oncology

Year:

2005

Language:

english

File:

PDF, 224 KB

english, 2005

66

ONCOLOGY: An Evidence-Based Approach. Edited by Alfred E. Chang, MD, Patricia A. Ganz, MD, Daniel F. Hayes, MD, Timothy J. Kinsella, MD, Harvey I. Pass, MD, Joan H. Schiller, MD, Richard M. Stone, MD, Victor J. Strecher, PhD, MPH. Springer Science and Business Media, Inc., New York, 2006.

Ioannis Kalogiannidis, Ignace Vergote

Journal:

Gynecologic Oncology

Year:

2007

Language:

english

File:

PDF, 79 KB

english, 2007

67

Transition of endometrial stromal sarcoma into high-grade sarcoma

Frederic Amant, Heidi Woestenborghs, Vanessa Vandenbroucke, Patrick Berteloot, Patrick Neven, Philippe Moerman, Ignace Vergote

Journal:

Gynecologic Oncology

Year:

2006

Language:

english

File:

PDF, 809 KB

english, 2006

68

Time to include high-risk early ovarian cancer in randomized phase III trials of advanced ovarian cancer

Ignace Vergote, Frederic Amant

Journal:

Gynecologic Oncology

Year:

2006

Language:

english

File:

PDF, 80 KB

english, 2006

69

A new prognostic model for FIGO stage 1 epithelial ovarian cancer

Andreas Obermair, Arlan Fuller, Elisa Lopez-Varela, Toon van Gorp, Ignace Vergote, Lynne Eaton, Jeff Fowler, Michael Quinn, Ian Hammond, Donald Marsden, Anthony Proietto, Jonathan Carter, Margaret Dav

Journal:

Gynecologic Oncology

Year:

2007

Language:

english

File:

PDF, 151 KB

english, 2007

70

S. Arulkumaran,Editors, ,Emergencies in obstetrics and gynaecology First edition (2006) Oxford University Press,Oxford, UK 297 pp..

Tim Van Mieghem, Ignace Vergote

Journal:

Gynecologic Oncology

Year:

2007

Language:

english

File:

PDF, 76 KB

english, 2007

71

M.M. Boyiadzis, P.F. Lebowitz, J.N. Frame, T. Fojo, ,Hematology-oncology therapy (2007) McGraw Hill Medical.

Isabelle Cadron, Ignace Vergote

Journal:

Gynecologic Oncology

Year:

2007

Language:

english

File:

PDF, 72 KB

english, 2007

72

Dormant foci of endometrial stromal sarcoma as an intermediate between an indolent and aggressive growth

Frederic Amant, Philippe Moerman, Ignace Vergote

Journal:

Gynecologic Oncology

Year:

2007

Language:

english

File:

PDF, 386 KB

english, 2007

73

Modulation of CA-125 tumor marker shedding in ovarian cancer cells by erlotinib or cetuximab

Christian Marth, Daniel Egle, Doris Auer, Julia Rössler, Alain G. Zeimet, Ignace Vergote, Günter Daxenbichler

Journal:

Gynecologic Oncology

Year:

2007

Language:

english

File:

PDF, 208 KB

english, 2007

74

The “Leuven” dose-dense paclitaxel/carboplatin regimen in patients with recurrent ovarian cancer

Isabelle Cadron, Karin Leunen, Frédéric Amant, Toon Van Gorp, Patrick Neven, Ignace Vergote

Journal:

Gynecologic Oncology

Year:

2007

Language:

english

File:

PDF, 310 KB

english, 2007

75

Chemotherapy for recurrent cervical cancer

Isabelle Cadron, Toon Van Gorp, Frederic Amant, Karin Leunen, Patrick Neven, Ignace Vergote

Journal:

Gynecologic Oncology

Year:

2007

Language:

english

File:

PDF, 157 KB

english, 2007

76

The impact of enzastaurin (LY317615.HCl) on CA125 biosynthesis and shedding in ovarian cancer cells

Isabelle Cadron, Toon Van Gorp, Attila Mihalyi, Catherina Luyten, Katrien Drijkoningen, Frederic Amant, Karin Leunen, Ignace Vergote

Journal:

Gynecologic Oncology

Year:

2010

Language:

english

File:

PDF, 671 KB

english, 2010

77

What is the role of neoadjuvant chemotherapy in advanced endometrial cancer?

Frédéric Amant, Ignace Vergote

Journal:

Gynecologic Oncology

Year:

2010

Language:

english

File:

PDF, 104 KB

english, 2010

78

Neoadjuvant chemotherapy in advanced ovarian cancer: What kind of evidence is needed to convince US gynaecological oncologists?

Ignace Vergote, Frederic Amant, Karin Leunen

Journal:

Gynecologic Oncology

Year:

2010

Language:

english

File:

PDF, 116 KB

english, 2010

79

The 13th Biennial Meeting of the International Gynecologic Cancer Society (IGCS 2010)

Chyong-Huey Lai, Angel Chao, Frederic Amant, Ignace Vergote

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 113 KB

english, 2011

80

Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: Analysis from the GCIG CALYPSO relapsing ovarian cancer trial

Florence Joly, Isabelle Ray-Coquard, Michel Fabbro, Mark Donoghoe, Karin Boman, Akira Sugimoto, Michelle Vaughan, Alexander Reinthaller, Ignace Vergote, Gabriella Ferrandina, Tiziana Dell'Anna, Jens H

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 178 KB

english, 2011

81

Primary surgery or neoadjuvant chemotherapy in ovarian cancer: What is the value of comparing apples with oranges?

Ignace Vergote, Karin Leunen, Frédéric Amant

Journal:

Gynecologic Oncology

Year:

2012

Language:

english

File:

PDF, 104 KB

english, 2012

82

A randomized trial on the use of ultrasonography or office hysteroscopy for endometrial assessment in postmenopausal patients with breast cancer who were treated with tamoxifen

Dirk Timmerman, Jan Deprest, Tom Bourne, Ivo Van den Berghe, William P. Collins, Ignace Vergote

Journal:

American Journal of Obstetrics and Gynecology

Year:

1998

Language:

english

File:

PDF, 1.15 MB

english, 1998

83

Trocar implantation metastasis after laparoscopy in patients with advanced ovarian cancer: Can the risk be reduced?

Peter A. van Dam, Jan DeCloedt a, Wiebren A.A. Tjalma, Philippe Buytaert, Dominique Becquart, Ignace B. Vergote

Journal:

American Journal of Obstetrics and Gynecology

Year:

1999

Language:

english

File:

PDF, 35 KB

english, 1999

84

A comparison of methods for preoperative discrimination between malignant and benign adnexal masses: The development of a new logistic regression model

Dirk Timmerman, Thomas H. Bourne, Anil Tailor, William P. Collins, Herman Verrelst, Kamiel Vandenberghe, Ignace Vergote

Journal:

American Journal of Obstetrics and Gynecology

Year:

1999

Language:

english

File:

PDF, 214 KB

english, 1999

85

Altretamine (hexamethylmelamine) in the treatment of platinum-resistant ovarian cancer: a phase II study

Nina Keldsen, Hanne Havsteen, Ignace Vergote, Kamma Bertelsen, Anders Jakobsen

Journal:

Gynecologic Oncology

Year:

2003

Language:

english

File:

PDF, 65 KB

english, 2003

86

Immunohistochemical determination of hormone receptors in uterine adenosarcomas

F.rédéric Amant, Charlotte Gabriel, Philippe Moerman, Ignace Vergote

Journal:

Gynecologic Oncology

Year:

2003

Language:

english

File:

PDF, 228 KB

english, 2003

87

Phase II study of gemcitabine in recurrent platinum-and paclitaxel-resistant ovarian cancer

Giuseppe D’Agostino, Frederic Amant, Patrick Berteloot, Giovanni Scambia, Ignace Vergote

Journal:

Gynecologic Oncology

Year:

2003

Language:

english

File:

PDF, 61 KB

english, 2003

88

Endometrial stromal sarcoma with a sole t(X;17) chromosome change: report of a case and review of the literature

F.rédéric Amant, Philippe Moerman, Isabelle Cadron, Anne Hagemeijer, Ignace Vergote, Maria Debiec-Rychter

Journal:

Gynecologic Oncology

Year:

2003

Language:

english

File:

PDF, 126 KB

english, 2003

89

The diagnostic problem of endometrial stromal sarcoma: report on six cases

Frédéric Amant, Philippe Moerman, Isabelle Cadron, Patrick Neven, Patrick Berteloot, Ignace Vergote

Journal:

Gynecologic Oncology

Year:

2003

Language:

english

File:

PDF, 814 KB

english, 2003

90

Transition of epithelial toward mesenchymal differentiation during ovarian carcinosarcoma tumorigenesis

Frederic Amant, Veerle Vloeberghs, Heidi Woestenborghs, Philippe Moerman, Ignace Vergote

Journal:

Gynecologic Oncology

Year:

2003

Language:

english

File:

PDF, 176 KB

english, 2003

91

Endometrial stromal sarcoma presenting as postpartum haemorrhage: report of a case with a sole t(10;17)(q22;p13) translocation

Karin Leunen, Frederic Amant, Maria Debiec-Rychter, Romaric Croes, Anne Hagemeijer, Eric F.P.M Schoenmakers, Ignace Vergote

Journal:

Gynecologic Oncology

Year:

2003

Language:

english

File:

PDF, 531 KB

english, 2003

92

2-methoxyestradiol strongly inhibits human uterine sarcomatous cell growth

Frederic Amant, Mona-Liza Lottering, Annie Joubert, Veneesha Thaver, Ignace Vergote, B.G Lindeque

Journal:

Gynecologic Oncology

Year:

2003

Language:

english

File:

PDF, 396 KB

english, 2003

93

Ovarian germ cell tumor with chromosome 12 anomaly but without i(12p)

Paola Dal Cin, Peter Marynen, Philippe Moerman, Ignace Vergot, Herman Van Den Berghe

Journal:

Cancer Genetics and Cytogenetics

Year:

1996

Language:

english

File:

PDF, 937 KB

english, 1996

94

Tamoxifen, screening and new oestrogen receptor modulators

Patrick Neven, Ignace Vergote

Journal:

Best Practice & Research Clinical Obstetrics & Gynaecology

Year:

2001

Language:

english

File:

PDF, 716 KB

english, 2001

95

Introduction

Robert F. Ozols, Ignace Vergote

Journal:

Seminars in Oncology

Year:

2006

Language:

english

File:

PDF, 61 KB

english, 2006

96

Validating the impact of a molecular subtype in ovarian cancer on outcomes: A study of the OVCAD Consortium

Dietmar Pils, Gudrun Hager, Dan Tong, Stefanie Aust, Georg Heinze, Maria Kohl, Eva Schuster, Andrea Wolf, Jalid Sehouli, Ioana Braicu, Ignace Vergote, Isabelle Cadron, Sven Mahner, Gerda Hofstetter, P

Journal:

Year:

2012

Language:

english

File:

PDF, 210 KB

english, 2012

97

Expression profiling to predict the clinical behaviour of ovarian cancer fails independent evaluation

Olivier Gevaert, Frank De Smet, Toon Van Gorp, Nathalie Pochet, Kristof Engelen, Frederic Amant, Bart De Moor, Dirk Timmerman, Ignace Vergote

Journal:

Year:

2008

Language:

english

File:

PDF, 559 KB

english, 2008

98

α-Particle Radiotherapy with 211At-Labeled Monodisperse Polymer Particles, 211At-Labeled IgG Proteins, and Free 211At in a Murine Intraperitoneal Tumor Model

Roy H. Larsen, Per Hoff, Ignace B. Vergote, Øyvind S. Bruland, Magne Aas, Laure De Vos, Kjell Nustad

Journal:

Gynecologic Oncology

Year:

1995

File:

PDF, 393 KB

1995

99

Meigs’ Syndrome with Elevated Serum CA 125 Levels: Two Case Reports and Review of the Literature

Dirk Timmerman, Philippe Moerman, Ignace Vergote

Journal:

Gynecologic Oncology

Year:

1995

Language:

english

File:

PDF, 64 KB

english, 1995

100

A comparison of fulvestrant and the third-generation aromatase inhibitors in the second-line treatment of postmenopausal women with advanced breast cancer

David Dodwell, Ignace Vergote

Journal:

Cancer Treatment Reviews

Year:

2005

Language:

english

File:

PDF, 317 KB

english, 2005

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски